Clinical trial · Interventional
Gastric Cancer Prevention for Indigenous Peoples
A Gastric Cancer Prevention Program for Aboriginal People Living in the Remote Areas
NCT03900910CI-TRIAL-00101334recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The incidence of gastric cancer in local indigenous peoples is higher than the non-Indigenous counterpart in Taiwan. How to design an effective prevention strategy for gastric cancer is of importance. The present study aimed to identify the causes that may account for the health inequalities, allowing generation of a plan of action on the whole population scale.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Execution of the program | Other | — | UNRESOLVED |
| Gastric cancer prevention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Gastric cancer prevention
- description
- 13C-urea breath test and anti-H. pylori treatment for those who are tested positive.
- interventionNames
- Other: Gastric cancer prevention
- Other: Execution of the program
- type
- EXPERIMENTAL
- label
- The acceptability and applicability of the mass screening program
- description
- Our short-term outcome is the acceptability and feasibility of this screening program, which will be evaluated by answering whether the screening quality indicators can reach the minimal requirements.
- interventionNames
- Other: Gastric cancer prevention
- Other: Execution of the program
Primary outcomes (6)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 20-60 years * Mentally competent to be able to understand the consent form * Able to communicate with study staff for individuals Exclusion Criteria: * Pregnancy * Individuals with major comorbid diseases
References
Publications (1)
- DERIVEDLei WY, Lee JY, Chuang SL, Bair MJ, Chen CL, Wu JY, Wu DC, Tien O'Donnell F, Tien HW, Chen YR, Chiang TH, Hsu YH, Hsu TH, Hsieh PC, Lin LJ, Chia SL, Wu CC, Subeq YM, Wen SH, Chang HC, Lin YW, Sun KP, Chu CH, Wu MS, Graham DY, Chen HH, Lee YC. Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method. Gut. 2023 Nov 24;72(12):2231-2240. doi: 10.1136/gutjnl-2023-329871. PMID 37197905